Cargando…

Reply: Anticoagulation Challenges in Cancer Patients

Detalles Bibliográficos
Autor principal: Fradley, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352107/
https://www.ncbi.nlm.nih.gov/pubmed/34396348
http://dx.doi.org/10.1016/j.jaccao.2021.04.005
_version_ 1783736111840886784
author Fradley, Michael G.
author_facet Fradley, Michael G.
author_sort Fradley, Michael G.
collection PubMed
description
format Online
Article
Text
id pubmed-8352107
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83521072021-08-13 Reply: Anticoagulation Challenges in Cancer Patients Fradley, Michael G. JACC CardioOncol Letter to the Editor Elsevier 2021-06-15 /pmc/articles/PMC8352107/ /pubmed/34396348 http://dx.doi.org/10.1016/j.jaccao.2021.04.005 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Fradley, Michael G.
Reply: Anticoagulation Challenges in Cancer Patients
title Reply: Anticoagulation Challenges in Cancer Patients
title_full Reply: Anticoagulation Challenges in Cancer Patients
title_fullStr Reply: Anticoagulation Challenges in Cancer Patients
title_full_unstemmed Reply: Anticoagulation Challenges in Cancer Patients
title_short Reply: Anticoagulation Challenges in Cancer Patients
title_sort reply: anticoagulation challenges in cancer patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352107/
https://www.ncbi.nlm.nih.gov/pubmed/34396348
http://dx.doi.org/10.1016/j.jaccao.2021.04.005
work_keys_str_mv AT fradleymichaelg replyanticoagulationchallengesincancerpatients